Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

RecruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Pediatric Cancer
Interventions
OTHER

Peds Evolutionary Tumor Board (pedsETB)

The pedsETB consists of evolutionary biologists, mathematicians, research scientists, statisticians, data scientists, radiologists, pathologists, oncologists (surgical, radiation, medical, and pediatric), and clinical trial coordinators. The pedsETB membership is inclusive of members from the participating institutions. The pedsETB will generate hypotheses, mathematical models, and experiments from the discussion towards further integration of evolutionary ideas towards therapeutic strategies for participants. The pedsETB will collect data through a chart review regarding adherence and results of ETB recommendation.

Trial Locations (1)

33612

RECRUITING

Moffitt Cancer Center, Tampa

All Listed Sponsors
collaborator

National Pediatric Cancer Foundation

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER